Article
A SARS-CoV-2 Variant with L452R and E484Q Neutralization Resistance Mutations
6 May 2021
Abstract excerpt
The emergence of SARS-CoV-2 variants that reduce antibody neutralization and vaccine efficacy is of significant global concern. On 24 March 2021, the Indian SARS-CoV-2 Consortium on Genomics reported that a variant containing a unique combination of two spike receptor-binding domain (RBD) neutralization resistance mutations, L452R and E484Q, made up 15 to 20% of positive cases in the Maharashtra state, which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
